Buyang Huanwu decoction ameliorates myocardial injury and attenuates platelet activation by regulating the PI3 kinase/Rap1/integrin α(IIb)β(3) pathway

• Main Authors: Jiaming Gao (Author), Hao Guo (Author), Junmei Li (Author), Min Zhan (Author), Yue You (Author), Gaojie Xin (Author), Zixin Liu (Author), Xiaodi Fan (Author), Qinghe Gao (Author), Jianxun Liu (Author), Yehao Zhang (Author), Jianhua Fu (Author)
• Format: Book
• Published: BMC, 2024-08-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Abstract Background Buyang Huanwu Decoction (BYHWD) is a traditional Chinese medicine to treat the syndrome of qi deficiency and blood stasis. Platelets play an important role in regulating thrombus and inflammation after ischemic injury, studies have shown that BYHWD regulate myocardial fibrosis an...